Backers included holding company FPIM-SFPI, family offices Heran (Annie Vereecken) and RMM (Rudi Mariën) and existing investors PMV, Qbic, Theodorus, Innovation Fund and Volksvermogen.
The company intends to use the funds to further develop the Pillar Array technology platform, to expand the µPAC™ product range, and to scale up production and global sales.
Led by Managing Director Johan Devenyns, PharmaFluidics is a VUB spin-off that has developed micro-chip chromatography technology – the µPAC™ column series – for use in biomarker, diagnostics and drug research & development applications in the global biotech and pharma industries.
The company’s tech is used by academic labs in bio-analysis, bio-pharmaceuticals and diagnostics companies in Europe, the USA and Asia.
The µPAC™ started shipping commercially in September 2017.
FinSMEs
11/01/2018